ANNA LIANG: Open Payments
NPI 1982241261 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,631 in 116 payments from 18 companies in 2025. Trend: 2023 $1,677 · 2024 $1,530 · 2025 $2,631
Food & beverage: $2,427Education: $204
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 23 | $420 |
| Janssen Biotech, Inc. | 16 | $326 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $247 |
| Regeneron Healthcare Solutions, Inc. | 10 | $237 |
| Galderma Laboratories, L.P. | 7 | $199 |
| Biofrontera Inc. | 5 | $184 |
| Organon LLC | 8 | $176 |
| ABBVIE INC. | 11 | $173 |
| Novartis Pharmaceuticals Corporation | 6 | $160 |
| UCB, Inc. | 5 | $154 |
Products named: Zoryve, TREMFYA, DUPIXENT, VTAMA, COSENTYX, Bimzelx, NEMLUVIO, SKYRIZI.
Industry payments across NV — which companies pay providers there.
